电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

PROCR 抗体

Cited in 5+ publications. The 大鼠 单克隆 anti-PROCR antibody (Clone RCR-252) (ABIN2192007) specifically detects PROCR in WB, FACS 和 Func. The antibody is reactive with 人 samples.
产品编号 ABIN2192007
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for PROCR 抗体 (ABIN2192007)

抗原

See all PROCR 抗体
PROCR (Protein C Receptor, Endothelial (PROCR))

适用

  • 52
  • 13
  • 11

宿主

  • 46
  • 12
  • 9
大鼠

克隆类型

  • 47
  • 20
单克隆

标记

  • 43
  • 10
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This PROCR antibody is un-conjugated

应用范围

  • 44
  • 27
  • 16
  • 12
  • 11
  • 10
  • 10
  • 7
  • 6
  • 5
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Functional Studies (Func)

克隆位点

RCR-252
  • 过滤

    0.2 μm filtered
  • 应用备注

    For flow cytometry and Western blotdilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50. For functional studies, in vitro dilutions have to be optimized in user's experimental setting. Positive RE-1 (rat 3Y1 fibroblasts stably transfected with human EPCR. control Negative N1 cells control

    限制

    仅限研究用
  • 缓冲液

    PBS, containing 0.1 % bovine serum albumin.

    储存条件

    4 °C

    储存方法

    Product should be stored at 4 °C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.
  • Bae, Yang, Rezaie: "Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Issue 8, pp. 2867-72, (2007) (PubMed).

    Finigan, Dudek, Singleton, Chiang, Jacobson, Camp, Ye, Garcia: "Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation." in: The Journal of biological chemistry, Vol. 280, Issue 17, pp. 17286-93, (2005) (PubMed).

    Dömötör, Benzakour, Griffin, Yule, Fukudome, Zlokovic: "Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1." in: Blood, Vol. 101, Issue 12, pp. 4797-801, (2003) (PubMed).

    Sturn, Kaneider, Feistritzer, Djanani, Fukudome, Wiedermann: "Expression and function of the endothelial protein C receptor in human neutrophils." in: Blood, Vol. 102, Issue 4, pp. 1499-505, (2003) (PubMed).

    Ye, Fukudome, Tsuneyoshi, Satoh, Tokunaga, Sugawara, Mizokami, Kimoto: "The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries." in: Biochemical and biophysical research communications, Vol. 259, Issue 3, pp. 671-7, (1999) (PubMed).

  • 抗原

    PROCR (Protein C Receptor, Endothelial (PROCR))

    别名

    Endothelial Protein C Receptor

    背景

    The monoclonal antibody RCR-252 recognizes human endothelial protein C receptor (EPCR), a highly glycosylated type I transmembrane protein of 221-amino-acids. These amino acids comprise an extracellular domain, a 25-aa transmembrane domain, and a short (3 aa) intracytoplasmic sequence coding for an ~46 kDa protein. Deglycosylation will reduce the protein mass to 25 kDa. EPCR is expressed strongly on the endothelial cells of arteries and veins in heart and lung, less intensely in capillaries in the lung and skin, and not at all in the endothelium of small vessels of the liver and kidney. EPCR is the receptor for protein C, a key player in the anticoagulation pathway. The protein C anticoagulant pathway serves as a major system for controling thrombosis, limiting inflammatory responses, and potentially decreasing endothelial cell apoptosis in response to inflammatory cytokines and ischemia. The essential components of the pathway include thrombin, thrombomodulin, the endothelial cell protein C receptor (EPCR), protein C and protein S. The pathway is initiated when thrombin binds to thrombomodulin on the surface of endothelium. EPCR augments protein C activation by binding protein C and presenting it to the thrombin-thrombomodulin activation complex. Activated protein C (aPC) retains its ability to bind EPCR, and this complex appears to be involved in some of the cellular signaling mechanisms that down-regulate inflammatory cytokine formation (TNF, IL-6). EPCR is shed from the vasculature by inflammatory mediators and thrombin. EPCR binds to activated neutrophils in a process that involves proteinase 3 and Mac-1. Furthermore, EPCR can undergo translocation from the plasma membrane to the nucleus. EPCR can be cleaved to release a soluble form (sEPCR) in the circulation. This sEPCR is detected as a single species of 43 kDa, resulting from shedding of membrane EPCR by the action of a metalloprotease, which is stimulated by thrombin and by some inflammatory mediators. Soluble EPCR binds PC and aPC with similar affinity, but its binding to aPC inhibits the anticoagulant activity of aPC by blocking its binding to phospholipids and by abrogating its ability to inactivate factor Va. sEPCR can be detected in plasma. In normal persons, sEPCR is present in levels of 83.6 +/- 17.2 ng/mL. Elevated levels of sEPCR are positively correlated to a higher risk for thrombosis. Furthermore, a haplotype (A3 allele) has been linked to elevated levels of sEPCR (264 +/-174 ng/mL). Aliases Activated protein C receptor, CD201, Endothelial cell protein C receptor Immunogen Human EPCR-positive RE-1 cells
You are here: